<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Endogenous production of uric acid</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Endogenous production of uric acid</h1>
<div class="graphic"><div class="figure"><div class="ttl">Endogenous production of uric acid</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Excessive purine catabolism results in the production of hypoxanthine and xanthine, which are metabolized to uric acid via the enzymatic action of XO. This pathway can be blocked by the use of allopurinol, a hypoxanthine analog that competitively inhibits XO, and febuxostat, a non-purine thiazolecarboxylic acid derivative that selectively inhibits XO. After about two to three days, allopurinol and febuxostat result in increased excretion of both hypoxanthine, which is more soluble than uric acid, and xanthine, which is less soluble than uric acid. Preformed uric acid is not altered by allopurinol or febuxostat. UO, present in most mammals but not humans, oxidizes preformed uric acid to allantoin, which is 5 to 10 times more soluble than uric acid in acid urine. When exogenous UO (uricase, rasburicase, pegloticase) is administered, serum and urinary uric acid levels decrease markedly within approximately four hours.</div><div class="graphic_footnotes">XO: xanthine oxidase; UO: urate oxidase.<br/>* UO is not normally present in humans.</div><div id="graphicVersion">Graphic 79178 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
